cancer detection

Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation liquid biopsy tests…

Flexible subscription model accelerates deployment of iCAD’s Breast AI Suite, the only complete solution designed to comprehensively address today’s…

Delfi Diagnostics, a pioneering developer of next generation high performance, affordable liquid biopsy tests for early cancer detection, has enrolled…

New trade show initiative hopes to raise awareness, and fight cancer through early detection With a fresh take on the sometimes “meh” b2b trade show…

Exai Bio, a next-generation liquid biopsy company, announced it has raised a $67.5 million Series A financing to accelerate development of its…

Collaborating to Improve the Early Detection of Incidental Lung Nodules on Chest Radiographs Laurel Bridge Software, Inc., a provider of imaging…

Ibex Was Selected Among the First Ever Winners of the AI in Health and Care Award, Sharing £50 Million to Enable a Study of Ibex’s AI Technology…

Jefferson Radiology is implementing state-of-the-art artificial intelligence software for digital breast tomosynthesis (DBT) to improve cancer…

Promising Clinical Research Supports Xoft Brain IORT as a Viable Treatment Option for Glioblastoma Multiforme That May Extend Patients’ Lives iCAD,…

 iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it has partnered…